Extended haplotype analysis of cystic fibrosis mutations and its implications for the selective advantage hypothesis

The major cystic fibrosis (CF) mutation, delta F508, is associated with one haplotype (B) determined by the two polymorphic markers, XV2C and KM19. This haplotype is rare (15%) among non-CF chromosomes. Its frequency among non-delta F508 CF chromosomes is 50% with variation between populations. One...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human genetics 1993-10, Vol.92 (3), p.289-295
Hauptverfasser: SERETH, H, SHOSHANI, T, NURIT BASHAN, BAT-SHEVA KEREM
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 295
container_issue 3
container_start_page 289
container_title Human genetics
container_volume 92
creator SERETH, H
SHOSHANI, T
NURIT BASHAN
BAT-SHEVA KEREM
description The major cystic fibrosis (CF) mutation, delta F508, is associated with one haplotype (B) determined by the two polymorphic markers, XV2C and KM19. This haplotype is rare (15%) among non-CF chromosomes. Its frequency among non-delta F508 CF chromosomes is 50% with variation between populations. One hypothesis for the high frequency of CF haplotype B chromosomes suggests that there was a selective advantage for CF mutations on this specific "background" as a result of epistatic selection at other closely linked loci. Since the XV2C and KM19 markers are located 200 kb 5' to the CF gene and span only 60 kb, an extended haplotype analysis was needed to test this hypothesis. Haplotypes were determined for 183 CF and 120 non-CF Israeli chromosomes at the XV2C and KM19 loci and at three intragenic polymorphic sites (GATT in intron 6A, TUB18 in intron 19, and 24M in exon 24). Among the studied chromosomes the frequency of non-delta F508 CF chromosomes associated with haplotype B was 70% (88% among Ashkenazi CF chromosomes). Nine mutations (delta F508, W1282X, G542X, N1303K, 3849 + 10 kb C-->T, Q359K/T360K, S549I, S549R, and 1717-1G-->A) were identified among the studied chromosomes. These mutations accounted for 96% of CF chromosomes of Ashkenazi origin. Haplotype B was associated with seven of these (delta F508, W1282X, G542X, N1303K, Q359K/T360K, S549R, and 1717-1G-->A). The extended haplotype analysis revealed that in five of the seven mutations associated with the haplotype B, 97% of the chromosomes shared the same intragenic haplotype, 212. The variation found in 3% of the chromosomes was only in the GATT repeat. Two mutations, W1282X and 1717-1G-->A, were associated with a completely different intragenic haplotype, 121. The results of this study indicate that grouping of CF chromosome by haplotype analysis spanning a small extragenic region might not be sufficient. In addition, the results of the extended haplotype analysis indicate that all the studied CF chromosomes that carry the same mutation derived from the same origin. Furthermore, the results indicate that the majority of the CF mutations are associated with the same extended haplotype, supporting the selective advantage hypothesis.
doi_str_mv 10.1007/BF00244474
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75986465</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16771037</sourcerecordid><originalsourceid>FETCH-LOGICAL-c342t-e76bc7d68475e96cc515502ef171336e282ef4a731b6298c4f4582874825e6843</originalsourceid><addsrcrecordid>eNqFkc1LAzEQxYMotVYv3oUcxIOwmu_sHrW0KhS86HlJs7M2sl9u0uL-96a41KOnGeb95jG8QeiSkjtKiL5_XBLChBBaHKEpFZwllBF-jKaEC5IoTfUpOvP-kxAqMyYnaKJVRjVlUxQW3wGaAgq8MV3VhqEDbBpTDd553JbYDj44i0u37tv9qN4GE1zb-EgV2AWPXd1Vzo7Dsu1x2AD2UIENbhfNip1pgvkAvBm6NmrR5RydlKbycDHWGXpfLt7mz8nq9ell_rBKLBcsJKDV2upCpUJLyJS1kkpJGJTxdM4VsDT2wmhO14plqRWlkClLtUiZhLjFZ-jm17fr268t-JDXzluoKtNAu_W5llmqhJL_glRpTQnXEbz9BW2Mw_dQ5l3vatMPOSX5_hf53y8ifDW6btc1FAd0DD_q16NuvDVV2ZvGOn_ARJpljGj-A6MGkVo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16771037</pqid></control><display><type>article</type><title>Extended haplotype analysis of cystic fibrosis mutations and its implications for the selective advantage hypothesis</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>SERETH, H ; SHOSHANI, T ; NURIT BASHAN ; BAT-SHEVA KEREM</creator><creatorcontrib>SERETH, H ; SHOSHANI, T ; NURIT BASHAN ; BAT-SHEVA KEREM</creatorcontrib><description>The major cystic fibrosis (CF) mutation, delta F508, is associated with one haplotype (B) determined by the two polymorphic markers, XV2C and KM19. This haplotype is rare (15%) among non-CF chromosomes. Its frequency among non-delta F508 CF chromosomes is 50% with variation between populations. One hypothesis for the high frequency of CF haplotype B chromosomes suggests that there was a selective advantage for CF mutations on this specific "background" as a result of epistatic selection at other closely linked loci. Since the XV2C and KM19 markers are located 200 kb 5' to the CF gene and span only 60 kb, an extended haplotype analysis was needed to test this hypothesis. Haplotypes were determined for 183 CF and 120 non-CF Israeli chromosomes at the XV2C and KM19 loci and at three intragenic polymorphic sites (GATT in intron 6A, TUB18 in intron 19, and 24M in exon 24). Among the studied chromosomes the frequency of non-delta F508 CF chromosomes associated with haplotype B was 70% (88% among Ashkenazi CF chromosomes). Nine mutations (delta F508, W1282X, G542X, N1303K, 3849 + 10 kb C--&gt;T, Q359K/T360K, S549I, S549R, and 1717-1G--&gt;A) were identified among the studied chromosomes. These mutations accounted for 96% of CF chromosomes of Ashkenazi origin. Haplotype B was associated with seven of these (delta F508, W1282X, G542X, N1303K, Q359K/T360K, S549R, and 1717-1G--&gt;A). The extended haplotype analysis revealed that in five of the seven mutations associated with the haplotype B, 97% of the chromosomes shared the same intragenic haplotype, 212. The variation found in 3% of the chromosomes was only in the GATT repeat. Two mutations, W1282X and 1717-1G--&gt;A, were associated with a completely different intragenic haplotype, 121. The results of this study indicate that grouping of CF chromosome by haplotype analysis spanning a small extragenic region might not be sufficient. In addition, the results of the extended haplotype analysis indicate that all the studied CF chromosomes that carry the same mutation derived from the same origin. Furthermore, the results indicate that the majority of the CF mutations are associated with the same extended haplotype, supporting the selective advantage hypothesis.</description><identifier>ISSN: 0340-6717</identifier><identifier>EISSN: 1432-1203</identifier><identifier>DOI: 10.1007/BF00244474</identifier><identifier>PMID: 7691712</identifier><identifier>CODEN: HUGEDQ</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Alleles ; Base Sequence ; Biological and medical sciences ; cystic fibrosis ; Cystic Fibrosis - epidemiology ; Cystic Fibrosis - ethnology ; Cystic Fibrosis - genetics ; Cystic Fibrosis Transmembrane Conductance Regulator ; DNA Mutational Analysis ; DNA Primers ; Epistasis, Genetic ; Gastroenterology. Liver. Pancreas. Abdomen ; Gene Frequency ; Genes, Lethal ; Haplotypes ; Humans ; Israel - epidemiology ; Jews - genetics ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; man ; Medical sciences ; Membrane Proteins - genetics ; Molecular Epidemiology ; Molecular Sequence Data ; Mutation ; Other diseases. Semiology ; Polymerase Chain Reaction ; Polymorphism, Restriction Fragment Length ; Selection, Genetic</subject><ispartof>Human genetics, 1993-10, Vol.92 (3), p.289-295</ispartof><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c342t-e76bc7d68475e96cc515502ef171336e282ef4a731b6298c4f4582874825e6843</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4899207$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7691712$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SERETH, H</creatorcontrib><creatorcontrib>SHOSHANI, T</creatorcontrib><creatorcontrib>NURIT BASHAN</creatorcontrib><creatorcontrib>BAT-SHEVA KEREM</creatorcontrib><title>Extended haplotype analysis of cystic fibrosis mutations and its implications for the selective advantage hypothesis</title><title>Human genetics</title><addtitle>Hum Genet</addtitle><description>The major cystic fibrosis (CF) mutation, delta F508, is associated with one haplotype (B) determined by the two polymorphic markers, XV2C and KM19. This haplotype is rare (15%) among non-CF chromosomes. Its frequency among non-delta F508 CF chromosomes is 50% with variation between populations. One hypothesis for the high frequency of CF haplotype B chromosomes suggests that there was a selective advantage for CF mutations on this specific "background" as a result of epistatic selection at other closely linked loci. Since the XV2C and KM19 markers are located 200 kb 5' to the CF gene and span only 60 kb, an extended haplotype analysis was needed to test this hypothesis. Haplotypes were determined for 183 CF and 120 non-CF Israeli chromosomes at the XV2C and KM19 loci and at three intragenic polymorphic sites (GATT in intron 6A, TUB18 in intron 19, and 24M in exon 24). Among the studied chromosomes the frequency of non-delta F508 CF chromosomes associated with haplotype B was 70% (88% among Ashkenazi CF chromosomes). Nine mutations (delta F508, W1282X, G542X, N1303K, 3849 + 10 kb C--&gt;T, Q359K/T360K, S549I, S549R, and 1717-1G--&gt;A) were identified among the studied chromosomes. These mutations accounted for 96% of CF chromosomes of Ashkenazi origin. Haplotype B was associated with seven of these (delta F508, W1282X, G542X, N1303K, Q359K/T360K, S549R, and 1717-1G--&gt;A). The extended haplotype analysis revealed that in five of the seven mutations associated with the haplotype B, 97% of the chromosomes shared the same intragenic haplotype, 212. The variation found in 3% of the chromosomes was only in the GATT repeat. Two mutations, W1282X and 1717-1G--&gt;A, were associated with a completely different intragenic haplotype, 121. The results of this study indicate that grouping of CF chromosome by haplotype analysis spanning a small extragenic region might not be sufficient. In addition, the results of the extended haplotype analysis indicate that all the studied CF chromosomes that carry the same mutation derived from the same origin. Furthermore, the results indicate that the majority of the CF mutations are associated with the same extended haplotype, supporting the selective advantage hypothesis.</description><subject>Alleles</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>cystic fibrosis</subject><subject>Cystic Fibrosis - epidemiology</subject><subject>Cystic Fibrosis - ethnology</subject><subject>Cystic Fibrosis - genetics</subject><subject>Cystic Fibrosis Transmembrane Conductance Regulator</subject><subject>DNA Mutational Analysis</subject><subject>DNA Primers</subject><subject>Epistasis, Genetic</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Gene Frequency</subject><subject>Genes, Lethal</subject><subject>Haplotypes</subject><subject>Humans</subject><subject>Israel - epidemiology</subject><subject>Jews - genetics</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>man</subject><subject>Medical sciences</subject><subject>Membrane Proteins - genetics</subject><subject>Molecular Epidemiology</subject><subject>Molecular Sequence Data</subject><subject>Mutation</subject><subject>Other diseases. Semiology</subject><subject>Polymerase Chain Reaction</subject><subject>Polymorphism, Restriction Fragment Length</subject><subject>Selection, Genetic</subject><issn>0340-6717</issn><issn>1432-1203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1LAzEQxYMotVYv3oUcxIOwmu_sHrW0KhS86HlJs7M2sl9u0uL-96a41KOnGeb95jG8QeiSkjtKiL5_XBLChBBaHKEpFZwllBF-jKaEC5IoTfUpOvP-kxAqMyYnaKJVRjVlUxQW3wGaAgq8MV3VhqEDbBpTDd553JbYDj44i0u37tv9qN4GE1zb-EgV2AWPXd1Vzo7Dsu1x2AD2UIENbhfNip1pgvkAvBm6NmrR5RydlKbycDHWGXpfLt7mz8nq9ell_rBKLBcsJKDV2upCpUJLyJS1kkpJGJTxdM4VsDT2wmhO14plqRWlkClLtUiZhLjFZ-jm17fr268t-JDXzluoKtNAu_W5llmqhJL_glRpTQnXEbz9BW2Mw_dQ5l3vatMPOSX5_hf53y8ifDW6btc1FAd0DD_q16NuvDVV2ZvGOn_ARJpljGj-A6MGkVo</recordid><startdate>19931001</startdate><enddate>19931001</enddate><creator>SERETH, H</creator><creator>SHOSHANI, T</creator><creator>NURIT BASHAN</creator><creator>BAT-SHEVA KEREM</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T3</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19931001</creationdate><title>Extended haplotype analysis of cystic fibrosis mutations and its implications for the selective advantage hypothesis</title><author>SERETH, H ; SHOSHANI, T ; NURIT BASHAN ; BAT-SHEVA KEREM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c342t-e76bc7d68475e96cc515502ef171336e282ef4a731b6298c4f4582874825e6843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Alleles</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>cystic fibrosis</topic><topic>Cystic Fibrosis - epidemiology</topic><topic>Cystic Fibrosis - ethnology</topic><topic>Cystic Fibrosis - genetics</topic><topic>Cystic Fibrosis Transmembrane Conductance Regulator</topic><topic>DNA Mutational Analysis</topic><topic>DNA Primers</topic><topic>Epistasis, Genetic</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Gene Frequency</topic><topic>Genes, Lethal</topic><topic>Haplotypes</topic><topic>Humans</topic><topic>Israel - epidemiology</topic><topic>Jews - genetics</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>man</topic><topic>Medical sciences</topic><topic>Membrane Proteins - genetics</topic><topic>Molecular Epidemiology</topic><topic>Molecular Sequence Data</topic><topic>Mutation</topic><topic>Other diseases. Semiology</topic><topic>Polymerase Chain Reaction</topic><topic>Polymorphism, Restriction Fragment Length</topic><topic>Selection, Genetic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SERETH, H</creatorcontrib><creatorcontrib>SHOSHANI, T</creatorcontrib><creatorcontrib>NURIT BASHAN</creatorcontrib><creatorcontrib>BAT-SHEVA KEREM</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Human Genome Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Human genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SERETH, H</au><au>SHOSHANI, T</au><au>NURIT BASHAN</au><au>BAT-SHEVA KEREM</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extended haplotype analysis of cystic fibrosis mutations and its implications for the selective advantage hypothesis</atitle><jtitle>Human genetics</jtitle><addtitle>Hum Genet</addtitle><date>1993-10-01</date><risdate>1993</risdate><volume>92</volume><issue>3</issue><spage>289</spage><epage>295</epage><pages>289-295</pages><issn>0340-6717</issn><eissn>1432-1203</eissn><coden>HUGEDQ</coden><abstract>The major cystic fibrosis (CF) mutation, delta F508, is associated with one haplotype (B) determined by the two polymorphic markers, XV2C and KM19. This haplotype is rare (15%) among non-CF chromosomes. Its frequency among non-delta F508 CF chromosomes is 50% with variation between populations. One hypothesis for the high frequency of CF haplotype B chromosomes suggests that there was a selective advantage for CF mutations on this specific "background" as a result of epistatic selection at other closely linked loci. Since the XV2C and KM19 markers are located 200 kb 5' to the CF gene and span only 60 kb, an extended haplotype analysis was needed to test this hypothesis. Haplotypes were determined for 183 CF and 120 non-CF Israeli chromosomes at the XV2C and KM19 loci and at three intragenic polymorphic sites (GATT in intron 6A, TUB18 in intron 19, and 24M in exon 24). Among the studied chromosomes the frequency of non-delta F508 CF chromosomes associated with haplotype B was 70% (88% among Ashkenazi CF chromosomes). Nine mutations (delta F508, W1282X, G542X, N1303K, 3849 + 10 kb C--&gt;T, Q359K/T360K, S549I, S549R, and 1717-1G--&gt;A) were identified among the studied chromosomes. These mutations accounted for 96% of CF chromosomes of Ashkenazi origin. Haplotype B was associated with seven of these (delta F508, W1282X, G542X, N1303K, Q359K/T360K, S549R, and 1717-1G--&gt;A). The extended haplotype analysis revealed that in five of the seven mutations associated with the haplotype B, 97% of the chromosomes shared the same intragenic haplotype, 212. The variation found in 3% of the chromosomes was only in the GATT repeat. Two mutations, W1282X and 1717-1G--&gt;A, were associated with a completely different intragenic haplotype, 121. The results of this study indicate that grouping of CF chromosome by haplotype analysis spanning a small extragenic region might not be sufficient. In addition, the results of the extended haplotype analysis indicate that all the studied CF chromosomes that carry the same mutation derived from the same origin. Furthermore, the results indicate that the majority of the CF mutations are associated with the same extended haplotype, supporting the selective advantage hypothesis.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><cop>New York, NY</cop><pub>Springer</pub><pmid>7691712</pmid><doi>10.1007/BF00244474</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0340-6717
ispartof Human genetics, 1993-10, Vol.92 (3), p.289-295
issn 0340-6717
1432-1203
language eng
recordid cdi_proquest_miscellaneous_75986465
source MEDLINE; SpringerNature Journals
subjects Alleles
Base Sequence
Biological and medical sciences
cystic fibrosis
Cystic Fibrosis - epidemiology
Cystic Fibrosis - ethnology
Cystic Fibrosis - genetics
Cystic Fibrosis Transmembrane Conductance Regulator
DNA Mutational Analysis
DNA Primers
Epistasis, Genetic
Gastroenterology. Liver. Pancreas. Abdomen
Gene Frequency
Genes, Lethal
Haplotypes
Humans
Israel - epidemiology
Jews - genetics
Liver. Biliary tract. Portal circulation. Exocrine pancreas
man
Medical sciences
Membrane Proteins - genetics
Molecular Epidemiology
Molecular Sequence Data
Mutation
Other diseases. Semiology
Polymerase Chain Reaction
Polymorphism, Restriction Fragment Length
Selection, Genetic
title Extended haplotype analysis of cystic fibrosis mutations and its implications for the selective advantage hypothesis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T21%3A53%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extended%20haplotype%20analysis%20of%20cystic%20fibrosis%20mutations%20and%20its%20implications%20for%20the%20selective%20advantage%20hypothesis&rft.jtitle=Human%20genetics&rft.au=SERETH,%20H&rft.date=1993-10-01&rft.volume=92&rft.issue=3&rft.spage=289&rft.epage=295&rft.pages=289-295&rft.issn=0340-6717&rft.eissn=1432-1203&rft.coden=HUGEDQ&rft_id=info:doi/10.1007/BF00244474&rft_dat=%3Cproquest_cross%3E16771037%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16771037&rft_id=info:pmid/7691712&rfr_iscdi=true